The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Inflammation and the pathogenesis of diabetic nephropathy
Abstract
The most problematic issue in clinical nephrology is the relentless and progressive increase in patients with ESRD (end-stage renal disease) worldwide. The impact of diabetic nephropathy on the increasing population with CKD (chronic kidney disease) and ESRD is enormous. Three major pathways showing abnormality of intracellular metabolism have been identified in the development of diabetic nephropathy: (i) the activation of polyol and PKC (protein kinase C) pathways; (ii) the formation of advanced glycation end-products; and (iii) intraglomerular hypertension induced by glomerular hyperfiltration. Upstream of these three major pathways, hyperglycaemia is the major driving force of the progression to ESRD from diabetic nephropathy. Downstream of the three pathways, microinflammation and subsequent extracellular matrix expansion are common pathways for the progression of diabetic nephropathy. In recent years, many researchers have been convinced that the inflammation pathways play central roles in the progression of diabetic nephropathy, and the identification of new inflammatory molecules may link to the development of new therapeutic strategies. Various molecules related to the inflammation pathways in diabetic nephropathy include transcription factors, pro-inflammatory cytokines, chemokines, adhesion molecules, Toll-like receptors, adipokines and nuclear receptors, which are candidates for the new molecular targets for the treatment of diabetic nephropathy. Understanding of these molecular pathways of inflammation would translate into the development of anti-inflammation therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Navarro-González, J. F., Mora-Fernández, C., de Fuentes, M. M., & García-Pérez, J. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.51 · Cited by 1,072
Gæde, P., Vedel, P., Parving, H.-H., & Pedersen, O. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07368-1 · Cited by 981
Ziyadeh, F. N., Hoffman, B. B., Han, D. C., Iglesias-de la Cruz, M. C., Hong, S. W., Isono, M., Chen, S., McGowan, T. A., & Sharma, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120055097 · Cited by 907
Tarlow, J., Blakemore, A. F., Lennard, A., Solari, R., Hughes, H., Steinkasserer, A., & Duff, G. (1993) · Human Genetics · doi:10.1007/bf00217368 · Cited by 677
Receptor for AGE (RAGE): Signaling mechanisms in the pathogenesis of diabetes and its complications
Ramasamy, R., Yan, S. F., & Schmidt, A. M. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06320.x · Cited by 521
Anders, H.-J., & Ryu, M. (2011) · Kidney International · doi:10.1038/ki.2011.217 · Cited by 486
KOYA, D., HANEDA, M., NAKAGAWA, H., ISSHIKI, K., SATO, H., MAEDA, S., SUGIMOTO, T., YASUDA, H., KASHIWAGI, A., WAYS, D. K., et al. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.3.439 · Cited by 427
Jagannathan-Bogdan, M., McDonnell, M. E., Shin, H., Rehman, Q., Hasturk, H., Apovian, C. M., & Nikolajczyk, B. S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002615 · Cited by 417
Tesch, G. H. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00016.2008 · Cited by 417
Toll-Like Receptor 4 Promotes Tubular Inflammation in Diabetic Nephropathy
Lin, M., Yiu, W. H., Wu, H. J., Chan, L. Y. Y., Leung, J. C. K., Au, W. S., Chan, K. W., Lai, K. N., & Tang, S. C. W. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111210 · Cited by 386
NF- B activation and overexpression of regulated genes in human diabetic nephropathy
Mezzano, S., Aros, C., Droguett, A., Burgos, M. E., Ardiles, L., Flores, C., Schneider, H., Ruiz-Ortega, M., & Egido, J. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh207 · Cited by 381
Low Production Capacity of Interleukin-10 Associates With the Metabolic Syndrome and Type 2 Diabetes
van Exel, E., Gussekloo, J., de Craen, A. J. M., Frölich, M., Bootsma-van der Wiel, A., & Westendorp, R. G. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1088 · Cited by 358
Satoh, M., Fujimoto, S., Haruna, Y., Arakawa, S., Horike, H., Komai, N., Sasaki, T., Tsujioka, K., Makino, H., & Kashihara, N. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00221.2004 · Cited by 354
Self-citationBerthier, C. C., Zhang, H., Schin, M., Henger, A., Nelson, R. G., Yee, B., Boucherot, A., Neusser, M. A., Cohen, C. D., Carter-Su, C., et al. (2009) · Diabetes · doi:10.2337/db08-1328 · Cited by 317
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Zhang, Z., Sun, L., Wang, Y., Ning, G., Minto, A. W., Kong, J., Quigg, R. J., & Li, Y. C. (2008) · Kidney International · doi:10.1038/sj.ki.5002572 · Cited by 305
Okada, S., Shikata, K., Matsuda, M., Ogawa, D., Usui, H., Kido, Y., Nagase, R., Wada, J., Shikata, Y., & Makino, H. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2586 · Cited by 298
Self-citationBradshaw, E. M., Raddassi, K., Elyaman, W., Orban, T., Gottlieb, P. A., Kent, S. C., & Hafler, D. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900576 · Cited by 297
IL-17 Immunity in Human Type 1 Diabetes
Honkanen, J., Nieminen, J. K., Gao, R., Luopajarvi, K., Salo, H. M., Ilonen, J., Knip, M., Otonkoski, T., & Vaarala, O. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000788 · Cited by 297
Effects of NADPH oxidase inhibitor in diabetic nephropathy
Asaba, K., Tojo, A., Onozato, M. L., Goto, A., Quinn, M. T., Fujita, T., & Wilcox, C. S. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00287.x · Cited by 296
Zhang, Z., Zhang, Y., Ning, G., Deb, D. K., Kong, J., & Li, Y. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803751105 · Cited by 289
Chow, F. Y., Nikolic-Paterson, D. J., Ozols, E., Atkins, R. C., & Tesch, G. H. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070612 · Cited by 277
Identification and immune regulation of 25-hydroxyvitamin D-1-α-hydroxylase in murine macrophages
Overbergh, L., Decallonne, B., Valckx, D., Verstuyf, A., Depovere, J., Laureys, J., Rutgeerts, O., Saint-Arnaud, R., Bouillon, R., & Mathieu, C. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2000.01204.x · Cited by 275
Ha, H., Yu, M. R., Choi, Y. J., Kitamura, M., & Lee, H. B. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v134894 · Cited by 273
Moriwaki, Y., Yamamoto, T., Shibutani, Y., Aoki, E., Tsutsumi, Z., Takahashi, S., Okamura, H., Koga, M., Fukuchi, M., & Hada, T. (2003) · Metabolism · doi:10.1053/meta.2003.50096 · Cited by 270
Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy
Hasegawa, G., Nakano, K., Sawada, M., Uno, K., Shibayama, Y., Ienaga, K., & Kondo, M. (1991) · Kidney International · doi:10.1038/ki.1991.308 · Cited by 268
Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients
Saraheimo, M., Teppo, A.-M., Forsblom, C., Fagerudd, J., & Groop, P.-H. (2003) · Diabetologia · doi:10.1007/s00125-003-1194-5 · Cited by 255
Farnesoid X Receptor Modulates Renal Lipid Metabolism, Fibrosis, and Diabetic Nephropathy
Jiang, T., Wang, X. X., Scherzer, P., Wilson, P., Tallman, J., Takahashi, H., Li, J., Iwahashi, M., Sutherland, E., Arend, L., et al. (2007) · Diabetes · doi:10.2337/db06-1642 · Cited by 236
Vaidya, V. S., Niewczas, M. A., Ficociello, L. H., Johnson, A. C., Collings, F. B., Warram, J. H., Krolewski, A. S., & Bonventre, J. V. (2011) · Kidney International · doi:10.1038/ki.2010.404 · Cited by 234
Role of the JAK/STAT signaling pathway in diabetic nephropathy
Marrero, M. B., Banes-Berceli, A. K., Stern, D. M., & Eaton, D. C. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00181.2005 · Cited by 219
Soetikno, V., Sari, F. R., Veeraveedu, P. T., Thandavarayan, R. A., Harima, M., Sukumaran, V., Lakshmanan, A. P., Suzuki, K., Kawachi, H., & Watanabe, K. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-35 · Cited by 219
Nakamura, A., Shikata, K., Hiramatsu, M., Nakatou, T., Kitamura, T., Wada, J., Itoshima, T., & Makino, H. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2890 · Cited by 218
Self-citationPPAR-γ agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-β
Kawai, T., Masaki, T., Doi, S., Arakawa, T., Yokoyama, Y., Doi, T., Kohno, N., & Yorioka, N. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2008.104 · Cited by 203
Ohga, S., Shikata, K., Yozai, K., Okada, S., Ogawa, D., Usui, H., Wada, J., Shikata, Y., & Makino, H. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00288.2005 · Cited by 203
Self-citationPPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Park, C. W., Zhang, Y., Zhang, X., Wu, J., Chen, L., Cha, D. R., Su, D., Hwang, M.-T., Fan, X., Davis, L., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5000209 · Cited by 202
The role of TNF-α in diabetic nephropathy: Pathogenic and therapeutic implications
NAVARRO, J., & MORAFERNANDEZ, C. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.09.011 · Cited by 198
Wolf, G., & Ziyadeh, F. N. (2006) · Contributions to Nephrology · doi:10.1159/000095328 · Cited by 195
Sugimoto, H., Shikata, K., Hirata, K., Akiyama, K., Matsuda, M., Kushiro, M., Shikata, Y., Miyatake, N., Miyasaka, M., & Makino, H. (1997) · Diabetes · doi:10.2337/diab.46.12.2075 · Cited by 193
Self-citationPathogenic perspectives for the role of inflammation in diabetic nephropathy
Rivero, A., Mora, C., Muros, M., García, J., Herrera, H., & Navarro-González, J. F. (2009) · Clinical Science · doi:10.1042/cs20080394 · Cited by 190
Wang, X. X., Jiang, T., Shen, Y., Caldas, Y., Miyazaki-Anzai, S., Santamaria, H., Urbanek, C., Solis, N., Scherzer, P., Lewis, L., et al. (2010) · Diabetes · doi:10.2337/db10-0019 · Cited by 186
Hofmann, M. A., Schiekofer, S., Isermann, B., Kanitz, M., Henkels, M., Joswig, M., Treusch, A., Morcos, M., Weiss, T., Borcea, V., et al. (1999) · Diabetologia · doi:10.1007/s001250051142 · Cited by 183
Advanced Glycation End-Products Induce Tubular CTGF via TGF-β–Independent Smad3 Signaling
Chung, A. C. K., Zhang, H., Kong, Y.-Z., Tan, J.-J., Huang, X. R., Kopp, J. B., & Lan, H. Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009010018 · Cited by 180
ACE Inhibitors Improve Diabetic Nephropathy Through Suppression of Renal MCP-1
Amann, B., Tinzmann, R., & Angelkort, B. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2421 · Cited by 179
Wang, X., Shaw, S., Amiri, F., Eaton, D. C., & Marrero, M. B. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3505 · Cited by 176
In Situ Hybridization of Interleukin 6 in Diabetic Nephropathy
Suzuki, D., Miyazaki, M., Naka, R., Koji, T., Yagame, M., Jinde, K., Endoh, M., Nomoto, Y., & Sakai, H. (1995) · Diabetes · doi:10.2337/diab.44.10.1233 · Cited by 175
Zhang, Z., Yuan, W., Sun, L., Szeto, F. L., Wong, K. E., Li, X., Kong, J., & Li, Y. C. (2007) · Kidney International · doi:10.1038/sj.ki.5002296 · Cited by 173
Alderson, N. L., Chachich, M. E., Youssef, N. N., Beattie, R. J., Nachtigal, M., Thorpe, S. R., & Baynes, J. W. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00027.x · Cited by 171
Expression of VCAM-1 in the Normal and Diseased Kidney
Seron, D., Cameron, J. S., & Haskard, D. O. (1991) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/6.12.917 · Cited by 171
Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy
Sanchez-Niño, M.-D., Bozic, M., Córdoba-Lanús, E., Valcheva, P., Gracia, O., Ibarz, M., Fernandez, E., Navarro-Gonzalez, J. F., Ortiz, A., & Valdivielso, J. M. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00090.2011 · Cited by 171
Transcription factors in the pathogenesis of diabetic nephropathy
Sanchez, A. P., & Sharma, K. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001057 · Cited by 167
Sayyed, S. G., Hägele, H., Kulkarni, O. P., Endlich, K., Segerer, S., Eulberg, D., Klussmann, S., & Anders, H.-J. (2009) · Diabetologia · doi:10.1007/s00125-009-1493-6 · Cited by 166
Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy
Kanamori, H., Matsubara, T., Mima, A., Sumi, E., Nagai, K., Takahashi, T., Abe, H., Iehara, N., Fukatsu, A., Okamoto, H., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.148 · Cited by 166
Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney
Yang, T., Michele, D. E., Park, J., Smart, A. M., Lin, Z., Brosius, F. C., Schnermann, J. B., & Briggs, J. P. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.277.6.f966 · Cited by 162
Kalantarinia, K., Awad, A. S., & Siragy, H. M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00237.x · Cited by 156
Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats
Kato, S., Luyckx, V. A., Ots, M., Lee, K., Ziai, F., Troy, J. L., Brenner, B. M., & Mackenzie, H. S. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00643.x · Cited by 153
Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus
Blakemore, A. I. F., Cox, A., González, A.-M., Maskill, J. K., Hughes, M. E., Wilson, R. M., Ward, J. D., & Duff, G. W. (1996) · Human Genetics · doi:10.1007/bf02185776 · Cited by 151
Clausen, P., Jacobsen, P. K., Rossing, K., Jensen, J. S., Parving, H. ‐., & Feldt‐Rasmussen, B. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00347.x · Cited by 150
Lee, F., Cao, Z., Long, D. M., Panagiotopoulos, S., Jerums, G., Cooper, M. E., & Forbes, J. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000135055.61833.a8 · Cited by 150
Jorsal, A., Tarnow, L., Frystyk, J., Lajer, M., Flyvbjerg, A., Parving, H., Vionnet, N., & Rossing, P. R. (2008) · Kidney International · doi:10.1038/ki.2008.201 · Cited by 144
Accelerated Diabetic Nephropathy in Mice Lacking the Peroxisome Proliferator–Activated Receptor α
Park, C. W., Kim, H. W., Ko, S., Chung, H. W., Lim, S. W., Yang, C. W., Chang, Y. S., Sugawara, A., Guan, Y., & Breyer, M. D. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1329 · Cited by 144
Devaraj, S., Tobias, P. S., Kasinath, B. S., Ramsamooj, R., Afify, A. M., & Jialal, I. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.228924 · Cited by 142
Tashiro, K., Koyanagi, I., Saitoh, A., Shimizu, A., Shike, T., Ishiguro, C., Koizumi, M., Funabïki, K., Horikoshi, S., Shirato, I., et al. (2002) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.2057 · Cited by 141
Role of the renin angiotensin system in diabetic nephropathy
Chawla, T., Sharma, D., & Singh, A. (2010) · World Journal of Diabetes · doi:10.4239/wjd.v1.i5.141 · Cited by 139
Park, C. W., Kim, J., Lee, J. W., Kim, Y. S., Ahn, H. J., Shin, Y. S., Kim, S.-Y., Choi, E. J., Chang, Y. S., & Bang, B. K. (2000) · Diabetologia · doi:10.1007/s001250051567 · Cited by 138
Interactions between Renin Angiotensin System and Advanced Glycation in the Kidney
Thomas, M. C., Tikellis, C., Burns, W. M., Bialkowski, K., Cao, Z., Coughlan, M. T., Jandeleit-Dahm, K. A. M., Cooper, M. E., & Forbes, J. M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010013 · Cited by 136
Ninichuk, V., Clauß, S., Kulkarni, O. P., Schmid, H., Segerer, S., Radomska, E., Eulberg, D., Buchner, K., Selve, N., Klußmann, S., et al. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070601 · Cited by 135
Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy
Luis-Rodríguez, D., Martínez‐Castelao, A., Górriz, J. L., De-Álvaro, F., & Navarro‐González, J. F. (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i1.7 · Cited by 132
Ko, G.-J., Kang, Y. S., Han, S. Y., Lee, M. H., Song, H. K., Han, K. H., Kim, H. K., Han, J., & Cha, D. R. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn157 · Cited by 132
Serum Adiponectin Is Increased in Type 1 Diabetic Patients With Nephropathy
Saraheimo, M., Forsblom, C. M., Fagerudd, J. A., Teppo, A., Pettersson-Fernholm, K., Frystyk, J., Flyvbjerg, A., Groop, P., & on behalf of the FinnDiane Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.6.1410 · Cited by 131
Deb, D. K., Sun, T., Wong, K. E., Zhang, Z., Ning, G., Zhang, Y., Kong, J., Shi, H., Chang, A., & Li, Y. C. (2010) · Kidney International · doi:10.1038/ki.2010.22 · Cited by 128
Expression and Function of Peroxisome Proliferator–Activated Receptor-γ in Mesangial Cells
Nicholas, S. B., Kawano, Y., Wakino, S., Collins, A. R., & Hsueh, W. A. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.722 · Cited by 127
Sayyed, S. G., Ryu, M., Kulkarni, O. P., Schmid, H., Lichtnekert, J., Grüner, S., Green, L., Mattei, P., Hartmann, G. R., & Anders, H. (2011) · Kidney International · doi:10.1038/ki.2011.102 · Cited by 126
Albertini, J., Valensi, P. E., Lormeau, B., Aurousseau, M. H., Ferrière, F., Attali, J. R., & Gattegno, L. (1998) · Diabetes Care · doi:10.2337/diacare.21.6.1008 · Cited by 124
Usefulness of a Highly Sensitive Urinary and Serum IL-6 Assay in Patients with Diabetic Nephropathy
Shikano, M., Sobajima, H., Yoshikawa, H., Toba, T., Kushimoto, H., Katsumata, H., Tomita, M., & Kawashima, S. (2000) · The Nephron journals/Nephron journals · doi:10.1159/000045634 · Cited by 121
Role of T Cells in Type 2 Diabetic Nephropathy
Wu, C., Sytwu, H., Lu, K., & Lin, Y. (2011) · Experimental Diabetes Research · doi:10.1155/2011/514738 · Cited by 118
Peripheral Total and Differential Leukocyte Count in Diabetic Nephropathy
Chung, F., Tsai, J. C. ‐., Chang, D., Shin, S., & Lee, Y. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1710 · Cited by 116
Darisipudi, M. N., Kulkarni, O. P., Sayyed, S. G., Ryu, M., Migliorini, A., Sagrinati, C., Parente, E., Vater, A., Eulberg, D., Klußmann, S., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.004 · Cited by 116
Javor, E. D., Moran, S. A., Young, J. R., Cochran, E. K., DePaoli, A. M., Oral, E. A., Turman, M. A., Blackett, P. R., Savage, D. B., O’Rahilly, S., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032140 · Cited by 114
Kang, Y. S., Lee, M., Song, H. K., Ko, G. J., Kwon, O. S., Lim, T. K., Kim, S. H., Han, S. Y., Han, K. H., Lee, J. E., et al. (2010) · Kidney International · doi:10.1038/ki.2010.263 · Cited by 113
Yılmaz, M. İ., Sağlam, M., Qureshi, A. R., Carrero, J. J., Çağlar, K., Eyileten, T., Sönmez, A., Cakir, E., Oğuz, Y., Vural, A., et al. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm828 · Cited by 111
Effect of TNF-α inhibition on urinary albumin excretion in experimental diabetic rats
Moriwaki, Y., Inokuchi, T., Yamamoto, A., Ka, T., Tsutsumi, Z., Takahashi, S., & Yamamoto, T. (2007) · Acta Diabetologica · doi:10.1007/s00592-007-0007-6 · Cited by 110
Goldberg, H. J., Whiteside, C. I., Hart, G. W., & Fantus, I. G. (2005) · Endocrinology · doi:10.1210/en.2005-0523 · Cited by 110
Deb, D. K., Chen, Y., Zhang, Z., Zhang, Y., Szeto, F. L., Wong, K. E., Kong, J., & Li, Y. C. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00002.2009 · Cited by 103
Thiazolidinediones Ameliorate Diabetic Nephropathy via Cell Cycle–Dependent Mechanisms
Okada, T., Wada, J., Hida, K., et al. (2006) · Diabetes · doi:10.2337/db05-1285 · Cited by 100
Self-citationNakamura, K., Yamagishi, S., Adachi, H., Matsui, T., Kurita‐Nakamura, Y., Takeuchi, M., Inoue, H., & Imaizumi, T. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.09.004 · Cited by 99
Sourris, K. C., & Forbes, J. M. (2009) · Current Drug Targets · doi:10.2174/138945009787122905 · Cited by 99
Jude, E. B., Douglas, J. T., Anderson, S. G., Young, M. J., & Boulton, A. J. M. (2002) · European Journal of Internal Medicine · doi:10.1016/s0953-6205(02)00014-6 · Cited by 94
Wu, C., Chen, J.-S., Lu, K., Chen, C., Lin, S., Chu, P., Sytwu, H., & Lin, Y. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.01.036 · Cited by 94
The Role of Interstitial Macrophages in Nephropathy of Type 2 Diabetic db/db Mice
Ninichuk, V., Khandoga, A. G., Segerer, S., Loetscher, P., Schlapbach, A., Révész, L., Feifel, R., Khandoga, A., Krombach, F., Nelson, P. J., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060937 · Cited by 92
Jialal, I., & Kaur, H. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0258-7 · Cited by 89
Sarnak, M. J., Poindexter, A. E., Wang, S.-R., Beck, G. J., Kusek, J. W., Marcovina, S. M., Greene, T., & Levey, A. S. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00677.x · Cited by 87
Detection of Serum IL-6 in Patients with Diabetic Nephropathy
Sekizuka, K., Tomino, Y., Sei, C., et al. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000188281 · Cited by 81
Asano, T., Wakisaka, M., Yoshinari, M., Iino, K., Sonoki, K., Iwase, M., & Fujishima, M. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00054-9 · Cited by 79
Makino, N., Maeda, T., Sugano, M., Satoh, S., Watanabe, R., & Abe, N. (2005) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.04.002 · Cited by 78
Kato, K., Osawa, H., Ochi, M., Kusunoki, Y., Ebisui, O., Ohno, K., Ohashi, J., Shimizu, I., Fujii, Y., Tanimoto, M., et al. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03063.x · Cited by 74
Self-citationLi, L., Emmett, N. L., Mann, D. R., & Zhao, X. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2009.009218 · Cited by 74
Matsushita, Y., Ogawa, D., Wada, J., Yamamoto, N., Shikata, K., Sato, C., Tachibana, H., Toyota, N., & Makino, H. (2011) · Diabetes · doi:10.2337/db10-1361 · Cited by 73
Self-citationImprovement of inflammatory responses associated with NF-κB pathway in kidneys from diabetic rats
Chen, L., Zhang, J., Zhang, Y., Wang, Y., & Wang, B. (2008) · Inflammation Research · doi:10.1007/s00011-006-6190-z · Cited by 70
Vijay, S. K., Mishra, M., Kumar, H., & Tripathi, K. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0054-7 · Cited by 69
Tomizawa, A., Hattori, Y., Inoue, T., Hattori, S., & Kasai, K. (2010) · Metabolism · doi:10.1016/j.metabol.2010.04.020 · Cited by 69
Fujita, T., Ogihara, N., Kamura, Y., Satomura, A., Fuke, Y., Shimizu, C., Wada, Y., & Matsumoto, K. (2010) · Acta Diabetologica · doi:10.1007/s00592-010-0178-4 · Cited by 66
Wang, W., Liu, F., & Chen, N. (2007) · Mediators of Inflammation · doi:10.1155/2007/62641 · Cited by 65
Increased Expression of Toll-Like Receptor 2 in Rat Diabetic Nephropathy
Li, F., Yang, N., Zhang, L., Tan, H., Huang, B., Liang, Y., Chen, M., & Yu, X. (2010) · American Journal of Nephrology · doi:10.1159/000317023 · Cited by 63
Assignment of human ?-galactosidase-A gene to 3p21.33 by fluorescence in situ hybridization
Takano, T., & Yamanouchi, Y. (1993) · Human Genetics · doi:10.1007/bf01247344 · Cited by 61
Park, J., Ryu, D.-R., Li, J.-J., Jung, D., Kwak, S., Lee, S.-H., Yoo, T., Han, S., Lee, J. E., Kim, D., et al. (2008) · AJP - Renal Physiology · doi:10.1152/ajprenal.00547.2007 · Cited by 60
Balakumar, P., Kadian, S., & Mahadevan, N. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.01.004 · Cited by 59
Arora, M. K., Reddy, K., & Balakumar, P. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.03.002 · Cited by 58
High levels of circulating interleukin-10 in diabetic nephropathy patients.
Myśliwska, J. M., Zorena, K., Semetkowska-Jurkiewicz, E., Rachoń, D., Suchanek, H., & Myśliwski, A. (2005) · PubMed · Cited by 58
Fractalkine and Its Receptor, CX3CR1, Upregulation in Streptozotocin-Induced Diabetic Kidneys
Kikuchi, Y., Ikee, R., Hemmi, N., Hyodo, N., Saigusa, T., Namikoshi, T., Yamada, M., Suzuki, S., & Miura, S. (2004) · Nephron Experimental Nephrology · doi:10.1159/000077594 · Cited by 56
Structural damage in diabetic nephropathy is associated with TNF-α system activity
Fernández‐Real, J. M., Vendrell, J. J., García, I., Ricart, W., & Vallés, M. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0349-y · Cited by 56
Prevention and reversal of renal injury by leptin in a new mouse model of diabetic nephropathy
Suganami, T., Mukoyama, M., Mori, K., Yokoi, H., Koshikawa, M., Sawai, K., Hidaka, S., Ebihara, K., Tanaka, T., Sugawara, A., et al. (2004) · The FASEB Journal · doi:10.1096/fj.04-2183fje · Cited by 56
Banes‐Berceli, A. K. L., Shaw, S., Ma, G., et al. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00502.2005 · Cited by 54
Matsui, H., Suzuki, M., Tsukuda, R., et al. (1996) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(96)01209-0 · Cited by 53
LR-90 prevents dyslipidaemia and diabetic nephropathy in the Zucker diabetic fatty rat
Figarola, J. L., Loera, S., Weng, Y., Shanmugam, N., Natarajan, R. D., & Rahbar, S. (2008) · Diabetologia · doi:10.1007/s00125-008-0935-x · Cited by 49
Nam, J. S., Cho, M. H., Lee, G. T., Park, J. S., Ahn, C. W., Soo, B., Lim, S. K., Kim, K. R., Ha, H., & Lee, H. C. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.01.032 · Cited by 49
Fruehwald‐Schultes, B., Kern, W., Beyer, J., Forst, T. M., Pfützner, A., & Peters, A. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90270-6 · Cited by 49
Shelbaya, S., Amer, H., Seddik, S., Aa, A., Im, S., Mohamed, T. Y. H., & El Mosely, M. (2012) · PubMed · Cited by 48
Liang, Y., Jian, J., Liu, Y.-C., Juang, S.-J., Shyu, K., Lai, L., Wang, B., & Leu, J. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1100 · Cited by 47
Lee, W., Chen, H., Chih-Ying, W. A. N. G., Pei-Ying, L. I. N., Tin-Tsz, O. U., Chen-Chang, C. H. E. N., Wen, M., Wang, J. C. K., & Lee, H. (2010) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.90938 · Cited by 45
Yang, B., Hodgkinson, A., Oates, P. J., Millward, B. A., & Demaine, A. G. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.01.009 · Cited by 45
Role of oxidative stress and inflammation in the origin of Type 2 diabetes – a paradigm shift
Pillarisetti, S., & Saxena, U. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.5.401 · Cited by 44
Skopiński, P., Rogala, E., Duda-Król, B., Lipińska, A., Sommer, E., Chorostowska‐Wynimko, J., Szaflik, J., Partyka, I., & Skopińska-Różewska, E. (2005) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.02.008 · Cited by 43
Guo, L., Pan, Y., & Jin, H. M. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn770 · Cited by 39
Therapeutic Potential of Aleglitazar, a New Dual PPAR-α/γ Agonist
Cavender, M. A., & Lincoff, A. M. (2010) · American Journal of Cardiovascular Drugs · doi:10.2165/11539500-000000000-00000 · Cited by 39
Rudberg, S. L., & Persson, B. (1998) · Hormone Research in Paediatrics · doi:10.1159/000023294 · Cited by 36
Kumar, A., Hawkins, K. S., Hannan, M. A., et al. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.281.4.f613 · Cited by 34
Ohara, I., Tanimoto, M., Gohda, T., Yamazaki, T., Hagiwara, S., Murakoshi, M., Aoki, T., Toyoda, H., Ishikawa, Y., Funabiki, K., et al. (2010) · Nephron Experimental Nephrology · doi:10.1159/000320284 · Cited by 33
Ye, S. D., Zheng, M., Zhao, L., Qian, Y., Yao, X., Ren, A., Li, S. M., & Jing, C. Y. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02203.x · Cited by 30
Sarı, R., Balcı, M. K., & Apaydın, C. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0127 · Cited by 27
Nuclear Hormone Receptors as Therapeutic Targets
Levi, M., Wang, X., & Choudhury, D. (2011) · Contributions to nephrology · doi:10.1159/000325668 · Cited by 21
Bao, Y., Jia, R., Yuan, J. J., & Li, J. (2007) · Pharmacology · doi:10.1159/000103232 · Cited by 21
Shi, Y., Song, Z. H. A. O., Wang, C., Li, Y., & Duan, H. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00653.x · Cited by 20
Advanced glycation end-product induces fractalkine gene upregulation in normal rat glomeruli
Kikuchi, Y., Imakiire, T., Hyodo, T., Kushiyama, T., Higashi, K., Hyodo, N., Suzuki, S., & Miura, S. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi232 · Cited by 19
Svensson, M. K. E., & Eriksson, J. W. (2011) · Hormone and Metabolic Research · doi:10.1055/s-0031-1271622 · Cited by 17
Detection of Urinary MCP-1 in Patients withDiabetic Nephropathy
Saitoh, A., Sekizuka, K., Hayashi, T., Kaneko, S., Suzuki, Y., & Tomino, Y. (1998) · The Nephron journals/Nephron journals · doi:10.1159/000045142 · Cited by 16
Uzu, T., Yokoyama, H., Itoh, H., Koya, D., Nakagawa, A., Nishizawa, M., Maegawa, H., Yokomaku, Y., Araki, S., Abiko, A., et al. (2010) · Clinical and Experimental Nephrology · doi:10.1007/s10157-010-0343-7 · Cited by 15
Tissue-Specific Induction of E-Selectin in Glomeruli Is Augmented following Diabetes mellitus
Narumi, S., Onozato, M. L., Tojo, A., Sakamoto, S., & Tamatani, T. (2001) · The Nephron journals/Nephron journals · doi:10.1159/000046063 · Cited by 15
Chan, J. C. N., Ma, R. C. W., Chan, N. N., Ng, M. C. Y., Lee, Z. S. K., Lai, C. W. K., Tong, P. C. Y., So, W. Y., & Chan, J. C. N. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2003.10.023 · Cited by 14
Szeto, C., Chow, K.-M., Poon, P. Y., Kwan, B. C., & Li, P. K. (2009) · Nephrology · doi:10.1111/j.1440-1797.2008.01075.x · Cited by 10
Cited by
Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment
Samsu, N. (2021) · BioMed Research International · doi:10.1155/2021/1497449 · Cited by 1,001
Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition
Hameed, I., Masoodi, S. R., Mir, S. A., Nabi, M., Ghazanfar, K., & Ganai, B. A. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i4.598 · Cited by 506
Innate immunity in diabetes and diabetic nephropathy
Wada, J., & Makino, H. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.175 · Cited by 427
Self-citationDiabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury
Fakhruddin, S., Alanazi, W., & Jackson, K. E. (2017) · Journal of Diabetes Research · doi:10.1155/2017/8379327 · Cited by 292
Tuttle, K. R., Brosius, F. C., Adler, S. G., Kretzler, M., Mehta, R. L., Tumlin, J. A., Tanaka, Y., Haneda, M., Liu, J., Silk, M. E., et al. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx377 · Cited by 284
Metadata
- Authors
- Wada, J., & Makino, H.
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2012-10-02
- Volume
- 124
- Issue
- 3
- Pages
- 139-152
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2020133142
- Cited by
- 775
- References
- 142
- FWCI
- 23.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.